Concepedia

Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccine

Maryam Esmaily, Ali Masjedi, Shahin Hallaj, Mohsen Nabi‐Afjadi, Farinaz Malakotikhah, Sepideh Ghani, Armin Ahmadi, Mozhdeh Sojoodi, Hadi Hassannia, Fatemeh Atyabi,

Journal of Controlled Release · 2020 · 94 citations · 28 references

DOI

Concepts

References

28

A2A adenosine receptor protects tumors from antitumor T cells

Akio Ohta, Elieser Gorelik, Simon J. Prasad et al. · Proceedings of the National Academy of Sciences · 2006 · 1K citations

, , +16

Immunosuppression in Vivo by a Soluble Form of the CTLA-4 T Cell Activation Molecule

Peter S. Linsley, Philip M. Wallace, Jennifer Johnson et al. · Science · 1992 · 806 citations

, , +16

Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo.

K Inaba, Muneo Inaba, Makoto Naito et al. · The Journal of Experimental Medicine · 1993 · 481 citations · Full text

, , +16

Combination Therapy with Anti–CTLA-4 and Anti–PD-1 Leads to Distinct Immunologic Changes In Vivo

Rituparna Das, Rakesh Verma, Mario Sznol et al. · The Journal of Immunology · 2014 · 461 citations · Full text

, , +17

CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction

Elisabetta Contardi, Giulio Lelio Palmisano, Pier Luigi Tazzari et al. · International Journal of Cancer · 2005 · 323 citations · Full text

, , +17